1 / 22

SICU research meeting

SICU research meeting. Intern 粘展瑋 2007-01-21. Patient Profile. Name: 徐 X 光 Gender: male Age: 64-year-old Chart No.: 5046353 Bed No.: 4B1 07. Past History. Systemic disease: DM(-), HTN(-), CAD(-) Op history: Bilateral hip replacement 5 years ago

alaric
Download Presentation

SICU research meeting

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. SICU research meeting Intern 粘展瑋 2007-01-21

  2. Patient Profile • Name: 徐X光 • Gender: male • Age: 64-year-old • Chart No.: 5046353 • Bed No.: 4B1 07

  3. Past History • Systemic disease: DM(-), HTN(-), CAD(-) • Op history: Bilateral hip replacement 5 years ago • Smoking: 2~3 PPD for many years • Allergy: Denied

  4. Brief history I • 9505 Blood-tinged sputum, 恩主公H, Cytology: SCC CT: right hilar and subcarinal LAP and obstructive pneumonia of RUL. • 9506 NTUH, T4N2M0, stage IIIb Received CCRT( Taxotere+Cisplatin followed by 45Gy/25fx R/T ) • 9510 CT: encasement of right bronchus, pulmonary a., compression of SVC PET: residual malignancy at RUL • 951028 Operation: Right lung pneumonectomy+ SVC, RA, LA tumor excision+ SVC reconstruction+ temporal pacemaker

  5. Brief history II • 9511 Reintubation due to bronchospasm Extubation on 11/07 • 951109: Postero-lateral thoracotomy to repair of RMB stump for SC emphysema • 951128 Tracheostomy • 951206 K 6.3, acute renal failure CPR4min→ROSC, s/p CVVH • 951219 MDRPA ID: keep ABx, colistin + CMZ if S/C(+) • 950109 HSV infection in perianal and scrotum area • 950114 RUL stump repair for air leakage

  6. Lab data Platelet WBC

  7. HSV-related Thrombocytopenia

  8. Thrombocytopenia • Definition: PLT < 150,000/microL However, 2.5 % normal population have a platelet count lower than this. Clinical symptoms were rarely found unless PLT < 100,000/microL. • Life span of platelets 8 to 10 days • Production of platelet 35,000 to 50,000/microL/per day This value can be increased up to eight-fold during times of increased demand

  9. Cause of thrombocytopenia • Decreased platelet production Viral infections (ex. rubella, mumps, varicella, parvovirus, HCV, EBV), C/T or R/T, Bone marrow aplasia or hypoplasia, Alcohol toxicity, VitB-12 or folic acid deficiency • Increased platelet destruction ITP, SLE, Alloimmune destruction (posttransfusion, neonatal, post- transplantation ), DIC, TTP-HUS, HELLP syndrome, Antiphospholipid syndrome, Certain drugs (heparin, quinine, quinidine, and valproic acid), Infections (eg, infectious mononucleosis, CMV, HIV) ,Physical destruction of platelets during (CABG, IABP, huge aortic aneurysm) • Dilutional or distributional thrombocytopenia • Splenomegaly • Pseudothrombocytopenia

  10. Dilutional thrombocytopenia • Massive transfusion with packed RBC • Usual platelet count 47K~100K/microL after 15U PRBC in 24 hr 25K~ 61K /microL after 20U PRBC in 24 hr • Suggest giving platelet concentrates when patients receiving more than 20U PRBC in 24hr.

  11. Thrombocytopenia in the ICU • Infection, sepsis, septic shock • Use of heparin • Disseminated intravascular coagulation (DIC) • Massive blood transfusion • Post-transfusion purpura • Cardiopulmonary resuscitation • Cardiopulmonary bypass • Adult respiratory distress syndrome • Pulmonary embolism • Use of intravascular catheters • Solid organ allograft rejection • Use of drugs associated with thrombocytopenia

  12. Study • Predictors of thrombocytopenia developing Evolution of DIC Cardiopulmonary resuscitation Signs of organ failure • Septic shock, a higher APACHE II score, and a 30 % decrease in platelet counts were significant risk factors for ICU death Crit Care Med 2002 Aug;30(8):1765-71

  13. Our patient • Infection, sepsis, septic shock • Use of heparin • Disseminated intravascular coagulation (DIC) • Massive blood transfusion • Post-transfusion purpura • Cardiopulmonary resuscitation • Cardiopulmonary bypass • Adult respiratory distress syndrome • Pulmonary embolism • Use of intravascular catheters • Solid organ allograft rejection • Use of drugs associated with thrombocytopenia

  14. HSV-induced thrombocytopenia • Pathogenesis Tend to infect cells of ectodermal origin. After retrograde axonal flow from neurons at the viral point of entry and local replication, the viral genome becomes latent. • HSV viremia Immunocompromised population is most common Immunologically healthy individuals can occur, especially in pregnancy Disseminated infection can result in hepatitis, esophagitis, pneumonitis, encephalitis, and adrenal necrosis. • HSV hepatitis Leukopenia, thrombocytopenia, and disseminated intravascular coagulation E-medicine

  15. HSV hepatitis • Lab picture Marked elevation of liver transaminase values Slight increase in the bilirubin level Leukopenia and thrombocytopenia • Kaufmam et al, in their review, found a WBC count of <5,000/mm3 in 43% of patients. • Aboguddah et al, found a mortality rate of 81%; of cases reported between 1969 and 1980, 88% were fatal, and of cases reported from 1981 to 1989, 78% were fatal Clin Infect Dis 1997; 24:334-338 J Rheumatol 1991; 18:1406-1412

  16. South Med J 93(12):1212-1216, 2000

  17. In our patient 1/14: Transfusion PLT: 24U PRBC: 2U for operation 1/20 & 1/21 : PRBC 2U for Hb↓ r/o GI bleeding

  18. Diagnosis • Clinical picture Skin lesion • CT of liver Multiple low-density lesions • Liver biopsy is gold standard Of 52 reported cases, the correct diagnosis was made before death in only 23%. Clin Infect Dis 1997; 24:334-338

  19. Treatment • Acyclovir A review of the clinical experience with acyclovir in the treatment of HSV hepatitis shows that 13 of 21 patients survived. Transplantation 1995; 59:145-149

  20. Infection • Antibiotics for Pseudomonas aeruginosa Colistin(1221~) Fortum(1221~) Metronidazole(12/25~) Fortum was discontinued on 1/15

More Related